Literature DB >> 9343264

Construction of an adenovirus type 7a E1A- vector.

K Abrahamsen1, H L Kong, A Mastrangeli, D Brough, A Lizonova, R G Crystal, E Falck-Pedersen.   

Abstract

A strategy for constructing replication-defective adenovirus vectors from non-subgroup C viruses has been successfully demonstrated with adenovirus type 7 strain a (Ad7a) as the prototype. An E1A-deleted Ad7a reporter virus expressing the chloramphenicol acetyltransferase (CAT) gene from the cytomegalovirus promoter enhancer was constructed with DNA fragments isolated from Ad7a, an Ad7a recombination reporter plasmid, and the 293 cell line. The Ad7a-CAT virus particle transduces A549 cells as efficiently as Ad5-based vectors. Intravenous infections in a murine model indicate that the Ad7a-CAT virus infects a variety of tissues, with maximal levels of CAT gene expression found in the liver. The duration of Ad7a-CAT transgene expression in the liver was maximally maintained 2 weeks postinfection, with a decline to baseline activity by the week 4 postinfection. Ad7a-CAT represents the first example of a non-subgroup C E1A- adenovirus gene transfer vector.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343264      PMCID: PMC192370     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Isolation and characterization of adenovirus type 12 E1 host-range mutants defective for growth in nontransformed human cells.

Authors:  D E Breiding; C A Edbauer; J Y Tong; P Byrd; R J Grand; P H Gallimore; J Williams
Journal:  Virology       Date:  1988-06       Impact factor: 3.616

2.  Thirty-one human adenovirus serotypes (Ad1-Ad31) form five groups (A-E) based upon DNA genome homologies.

Authors:  M Green; J K Mackey; W S Wold; P Rigden
Journal:  Virology       Date:  1979-03       Impact factor: 3.616

Review 3.  Genetic variability of adenoviruses.

Authors:  G Wadell; M L Hammarskjöld; G Winberg; T M Varsanyi; G Sundell
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

4.  Comparison of the nucleotide sequences of early region E1b DNA of human adenovirus types 12, 7 and 5 (subgroups A, B and C).

Authors:  H van Ormondt; B Hesper
Journal:  Gene       Date:  1983-03       Impact factor: 3.688

5.  Comparison of nucleotide sequences of the early E1a regions for subgroups A, B and C of human adenoviruses.

Authors:  H van Ormondt; J Maat; R Dijkema
Journal:  Gene       Date:  1980-12       Impact factor: 3.688

6.  Gene organization of the transforming region of adenovirus type 7 DNA.

Authors:  R Dijkema; B M Dekker; H van Ormondt
Journal:  Gene       Date:  1982-05       Impact factor: 3.688

7.  The nucleotide sequence of the transforming BglII-H fragment of adenovirus type 7 DNA.

Authors:  R Dijkema; B M Dekker; H Van Ormondt
Journal:  Gene       Date:  1980-04       Impact factor: 3.688

8.  Demonstration of three different subtypes of adenovirus type 7 by DNA restriction site mapping.

Authors:  G Wadell; T M Varsanyi
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

9.  Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7.

Authors:  F H Top; E L Buescher; W H Bancroft; P K Russell
Journal:  J Infect Dis       Date:  1971-08       Impact factor: 5.226

10.  Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans.

Authors:  F H Top; R A Grossman; P J Bartelloni; H E Segal; B A Dudding; P K Russell; E L Buescher
Journal:  J Infect Dis       Date:  1971-08       Impact factor: 5.226

View more
  15 in total

1.  Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors.

Authors:  N Miyazawa; P L Leopold; N R Hackett; B Ferris; S Worgall; E Falck-Pedersen; R G Crystal
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein.

Authors:  N Miyazawa; R G Crystal; P L Leopold
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts.

Authors:  C Hidaka; E Milano; P L Leopold; J M Bergelson; N R Hackett; R W Finberg; T J Wickham; I Kovesdi; P Roelvink; R G Crystal
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

4.  Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity.

Authors:  Ronald Vogels; David Zuijdgeest; Richard van Rijnsoever; Eric Hartkoorn; Irma Damen; Marie-Pierre de Béthune; Stefan Kostense; Germaine Penders; Niels Helmus; Wouter Koudstaal; Marco Cecchini; Antoinette Wetterwald; Mieke Sprangers; Angelique Lemckert; Olga Ophorst; Björn Koel; Michelle van Meerendonk; Paul Quax; Laura Panitti; Jos Grimbergen; Abraham Bout; Jaap Goudsmit; Menzo Havenga
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

5.  Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41.

Authors:  Franck Lemiale; Hedi Haddada; Gary J Nabel; Douglas E Brough; C Richter King; Jason G D Gall
Journal:  Vaccine       Date:  2006-11-28       Impact factor: 3.641

Review 6.  Getting genetic access to natural adenovirus genomes to explore vector diversity.

Authors:  Wenli Zhang; Anja Ehrhardt
Journal:  Virus Genes       Date:  2017-07-15       Impact factor: 2.332

7.  Identification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors.

Authors:  Joseph T Bruder; Ping Chen; Elena Semenova; Charlie A Thomas; Svetlana Konovalova; Greg Ekberg; Damodar Ettyreddy; Duncan McVey; Jason G Gall; C Richter King; Douglas E Brough
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

8.  Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.

Authors:  Masahiko Hashimoto; Julie L Boyer; Neil R Hackett; James M Wilson; Ronald G Crystal
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

9.  Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs.

Authors:  B G Harvey; N R Hackett; T El-Sawy; T K Rosengart; E A Hirschowitz; M D Lieberman; M L Lesser; R G Crystal
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

10.  Atoh1 induces auditory hair cell recovery in mice after ototoxic injury.

Authors:  Shannon Kraft; Chi Hsu; Douglas E Brough; Hinrich Staecker
Journal:  Laryngoscope       Date:  2013-03-11       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.